OA11047A - Compositions pharmaceutiques stabilisées à base dequinupristine et de dalfopristine et leur prépara tion - Google Patents

Compositions pharmaceutiques stabilisées à base dequinupristine et de dalfopristine et leur prépara tion Download PDF

Info

Publication number
OA11047A
OA11047A OA9900100A OA9900100A OA11047A OA 11047 A OA11047 A OA 11047A OA 9900100 A OA9900100 A OA 9900100A OA 9900100 A OA9900100 A OA 9900100A OA 11047 A OA11047 A OA 11047A
Authority
OA
OAPI
Prior art keywords
pharmaceutical composition
solution
dalfopristine
quinupristine
composition according
Prior art date
Application number
OA9900100A
Other languages
English (en)
French (fr)
Inventor
Jean-Paul Bounine
Guillaume Conrath
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of OA11047A publication Critical patent/OA11047A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA9900100A 1996-11-19 1999-05-19 Compositions pharmaceutiques stabilisées à base dequinupristine et de dalfopristine et leur prépara tion OA11047A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614062A FR2755857B1 (fr) 1996-11-19 1996-11-19 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation

Publications (1)

Publication Number Publication Date
OA11047A true OA11047A (fr) 2003-03-07

Family

ID=9497744

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900100A OA11047A (fr) 1996-11-19 1999-05-19 Compositions pharmaceutiques stabilisées à base dequinupristine et de dalfopristine et leur prépara tion

Country Status (45)

Country Link
US (1) US5994338A (es)
EP (1) EP0949923B1 (es)
JP (1) JP4278115B2 (es)
KR (1) KR100530836B1 (es)
CN (1) CN1146417C (es)
AP (1) AP998A (es)
AR (1) AR008695A1 (es)
AT (1) ATE223217T1 (es)
AU (1) AU740291B2 (es)
BG (1) BG63621B1 (es)
BR (1) BR9713087A (es)
CA (1) CA2271095C (es)
CO (1) CO4910113A1 (es)
CZ (1) CZ299913B6 (es)
DE (1) DE69715247T2 (es)
DK (1) DK0949923T3 (es)
DZ (1) DZ2349A1 (es)
EA (1) EA002025B1 (es)
EE (1) EE03668B1 (es)
ES (1) ES2179375T3 (es)
FR (1) FR2755857B1 (es)
HK (1) HK1022832A1 (es)
HR (1) HRP970615B1 (es)
HU (1) HUP9904327A3 (es)
IL (2) IL129607A0 (es)
IN (1) IN187038B (es)
JO (1) JO1992B1 (es)
MA (1) MA26448A1 (es)
MY (1) MY123805A (es)
NO (1) NO992399L (es)
NZ (1) NZ334949A (es)
OA (1) OA11047A (es)
PE (1) PE13999A1 (es)
PL (1) PL190164B1 (es)
PT (1) PT949923E (es)
RS (1) RS49608B (es)
SA (1) SA97180645B1 (es)
SK (1) SK284311B6 (es)
TN (1) TNSN97184A1 (es)
TR (1) TR199901096T2 (es)
TW (1) TW474816B (es)
UA (1) UA59376C2 (es)
UY (1) UY24780A1 (es)
WO (1) WO1998022107A1 (es)
ZA (1) ZA9710435B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772272B1 (fr) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
PT1115417E (pt) * 1998-09-25 2006-07-31 Cubist Pharm Inc Utilizacao da daptomicina
ES2433678T3 (es) * 1999-03-03 2013-12-12 Eli Lilly & Company Formulaciones farmacéuticas de equinocandina que contienen tensioactivos formadores de micelas
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6119269A (en) * 1999-09-23 2000-09-19 Imler; Jack Fishing vest with removable storage container system
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
FR2812549B1 (fr) * 2000-08-03 2003-03-21 Aventis Pharma Sa Associations dalfopristine/quinupristine avec le cefpirome
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2599036B1 (fr) * 1986-05-22 1988-09-09 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HRP970615A2 (en) 1998-08-31
HUP9904327A2 (hu) 2000-06-28
BG103412A (en) 2000-06-30
EA199900479A1 (ru) 2000-02-28
TW474816B (en) 2002-02-01
HUP9904327A3 (en) 2002-03-28
ES2179375T3 (es) 2003-01-16
WO1998022107A1 (fr) 1998-05-28
IN187038B (es) 2001-12-29
CA2271095A1 (fr) 1998-05-28
DE69715247D1 (de) 2002-10-10
AU5125698A (en) 1998-06-10
DK0949923T3 (da) 2002-12-23
SK284311B6 (sk) 2005-01-03
CN1146417C (zh) 2004-04-21
EP0949923B1 (fr) 2002-09-04
JO1992B1 (en) 1999-05-15
DZ2349A1 (fr) 2002-12-28
RS49608B (sr) 2007-06-04
NZ334949A (en) 2000-12-22
BG63621B1 (bg) 2002-07-31
CN1233959A (zh) 1999-11-03
TNSN97184A1 (fr) 2005-03-15
PL190164B1 (pl) 2005-11-30
PE13999A1 (es) 1999-05-05
HRP970615B1 (en) 2002-12-31
JP4278115B2 (ja) 2009-06-10
NO992399D0 (no) 1999-05-19
AP998A (en) 2001-08-09
UY24780A1 (es) 2001-08-27
HK1022832A1 (en) 2000-08-25
CZ174899A3 (cs) 1999-08-11
EE9900127A (et) 1999-12-15
AU740291B2 (en) 2001-11-01
TR199901096T2 (xx) 1999-07-21
KR100530836B1 (ko) 2005-11-23
KR20000053343A (ko) 2000-08-25
SK66099A3 (en) 2000-01-18
PT949923E (pt) 2003-01-31
CO4910113A1 (es) 2000-04-24
FR2755857A1 (fr) 1998-05-22
MY123805A (en) 2006-06-30
EE03668B1 (et) 2002-04-15
US5994338A (en) 1999-11-30
ATE223217T1 (de) 2002-09-15
IL129607A0 (en) 2000-02-29
CA2271095C (fr) 2004-08-03
IL129607A (en) 2006-08-20
JP2001504475A (ja) 2001-04-03
EA002025B1 (ru) 2001-12-24
AR008695A1 (es) 2000-02-09
DE69715247T2 (de) 2003-04-30
YU22499A (sh) 2002-03-18
EP0949923A1 (fr) 1999-10-20
BR9713087A (pt) 2000-03-28
ZA9710435B (en) 1998-06-10
MA26448A1 (fr) 2004-12-20
FR2755857B1 (fr) 1998-12-24
SA97180645B1 (ar) 2005-12-12
UA59376C2 (uk) 2003-09-15
NO992399L (no) 1999-05-19
CZ299913B6 (cs) 2008-12-29

Similar Documents

Publication Publication Date Title
EP0858325B1 (fr) Formulation pharmaceutique lyophilisee stable
JP4268163B2 (ja) 製剤
AU2010321531B2 (en) Lipopeptide compositions and related methods
RU2345772C2 (ru) Лиофилизированные композиции cci-779
US7396841B2 (en) Injections
DK1993557T3 (en) NOVEL epoprostenol DEFINITION AND MANUFACTURING METHOD THEREOF
HUP0302567A2 (hu) Epotilon analógokat tartalmazó parenterális adagolási formák és eljárás az előállításukra
NZ567291A (en) Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases
CA2271095C (fr) Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
JP4142149B2 (ja) バンコマイシンの凍結乾燥製剤
WO1999030728A1 (fr) Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
US6020359A (en) Pharmaceutical composition
JP2007533724A (ja) 無秩序なセフォベシンナトリウム塩を安定させる方法
JPH0371409B2 (es)
MXPA04009201A (es) Solubilizacion de bases debiles.
CA2720183A1 (en) Liquid and freeze dried formulations
HU181759B (hu) Eljárás dihidroergotamin- vagy dihidroergotoxin-metán- vagy -etánszulfonát stabil vizes-alkoholos oldatainak az előállítására
JPH03240731A (ja) 制がん剤組成物